Valvular & structural heart disease

Effect of cerebral embolic protection device on new cerebral embolism during transcatheter aortic valve replacement: A prospective sentinel registry

Am Heart JPublished prospective Sentinel registry

Authors' conclusion

Among patients who are at high risk for stroke undergoing TAVR, the use of CEP was associated with a significant reduction of new cerebral embolism in protected brain territories. Because the study was underpowered to detect clinically relevant events, the results cannot be considered clinically directive.

Study context

Population
Patients undergoing transfemoral transcatheter aortic valve replacement (TAVR) who were considered at high risk for strokepatients included
Participants
219 patients
Exposure
Cerebral embolic protection (CEP) group vs control group
  • CEP groupn = 49
  • Control groupn = 170
Outcome
Number and volume of new cerebral lesions on brain magnetic resonance imaging (MRI) compared to baseline in protected brain territories
Follow-up
Postprocedure (2 to 7 days)
Methodological detailsimaging study, external control group from the ADAPT-TAVR trial
  • Imaging study
  • External control group from the ADAPT-TAVR trial

Main finding

As reported in the abstract

Difference

−4

P < 0.001

number of lesions; IQR, −6 to −3

Difference

−145.9

P < 0.001

volume of lesions; IQR, −296.7 to −67.1

CEP group

No. of lesions
1 (IQR, 1 to 2)
Volume of lesions
113.5 mm³ (IQR, 42.4-206.9)

Control group

No. of lesions
6 (IQR, 3 to 10)
Volume of lesions
283.5 mm³ (IQR, 129.7-682.4)

No. of lesions

CEP group1 (IQR, 1 to 2)
Control group6 (IQR, 3 to 10)

Volume of lesions

CEP group113.5 mm³ (IQR, 42.4-206.9)
Control group283.5 mm³ (IQR, 129.7-682.4)

Observational data: associations, not effects.

Safety

Strokes · 30 days

P = 0.64

Original publication

Effect of cerebral embolic protection device on new cerebral embolism during transcatheter aortic valve replacement: A prospective sentinel registry. Am Heart J. Published 14 August 2025. doi:10.1016/j.ahj.2025.08.006

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.